FIELD: organic chemistry.
SUBSTANCE: present invention relates namely to a compound or a pharmaceutically acceptable salt thereof selected from the group consisting of:
The invention also relates to a pharmaceutical composition and a method for treating cancer susceptible to inhibition of Bcl-2 proteins.
EFFECT: proposed new organic compounds, which are Bcl-2 protein inhibitors, suitable for cancer treatment.
9 cl, 4 dwg, 7 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2722560C1 |
| BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
| APOPTOSIS-INDUCING AGENTS FOR TREATING MALIGNANT TUMOURS AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2573832C2 |
| APOPTOSIS INDUCING AGENTS FOR TREATING MALIGNANT NEW GROWTH, AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2535347C2 |
| APOPTOSIS-INDUCING MEANS FOR TREATMENT OF MALIGNANT TUMOUR AND IMMUNE AND AUTOIMMUNE DISEASES | 2015 |
|
RU2628885C2 |
| APOPTOSIS-INDUCING AGENTS FOR TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2014 |
|
RU2662812C2 |
| APOPTOSIS-INDUCING MEDICATIONS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2554346C2 |
| SOLID DISPERSIONS CONTAINING AGENTS CAUSING APOPTOSIS | 2011 |
|
RU2598345C2 |
| SOLID DISPERSIONS PRODUCED BY MELT EXTRUSION AND CONTAINING APOPTOSIS-INDUCING AGENT | 2011 |
|
RU2577859C2 |
| SOLID DISPERSIONS PRODUCED BY MELT EXTRUSION AND CONTAINING APOPTOSIS-INDUCING AGENT | 2011 |
|
RU2633353C1 |
